Actionable news
All posts from Actionable news
Actionable news in CSCO: Cisco Systems, Inc.,

4 Large Cap Leaders Dominate Top Jefferies Stocks to Buy

With the third quarter now underway, and second-quarter earnings season looming, many investors are taking the proverbial halftime look at their portfolios and making some changes. After yet another solid first half of the year, and with earnings expectations rising, it’s a good bet that investors who have traded momentum may start rotating to stocks offering better value but still having large cap market size.

A recent Jefferies research report spotlights some top stocks to buy for the third quarter that are large cap leaders that have a value profile. We found four that look attractive now, and they make good sense for those who want to stay invested but lower potential portfolio volatility.

Abbott Laboratories

This top pharmaceutical and med-tech stock has very solid growth potential, but the shares have lagged the sector. Abbott Laboratories (NYSE: ABT) is a leading diversified global health care company that develops, manufactures and markets branded generics, medical devices, nutritional products and diagnostic solutions.

The company also offers a diversified large cap play as earnings are split between five well-positioned business segments: Nutritionals (31.0% of revenues), Vascular (13.0%), Generic Pharmaceuticals (20.0%), Diagnostics (25.5%) and Diabetes (10.5%).

Abbott Labs investors receive a 2.7% dividend. The Jefferies price target for the stock is $58, and the Wall Street consensus target is $50.47. Shares closed most recently at $48.71.


This top aerospace industrial has been on a roll since the election and has broken out to all-time highs. Boeing Co. (NYSE: BA), together with its...